Related references
Note: Only part of the references are listed.Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells
Tomasz Adamus et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano-Immunoadjuvant
Jingjing Wei et al.
ADVANCED SCIENCE (2022)
MMP9: A Tough Target for Targeted Therapy for Cancer
Katarzyna Augoff et al.
CANCERS (2022)
Regulation of the nucleic acid-sensing Toll-like receptors
Nicholas A. Lind et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Repolarization of glioblastoma macrophage cells using non-agonistic Dectin-1 ligand encapsulating TLR-9 agonist: plausible role in regenerative medicine against brain tumor
Rohit Kumar Tiwari et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2021)
Microglial TLR9: Plausible Novel Target for Therapeutic Regime Against Glioblastoma Multiforme
Rohit Kumar Tiwari et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2021)
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
Yang Xun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Type I and II interferons toward ideal vaccine and immunotherapy
Burcu Temizoz et al.
EXPERT REVIEW OF VACCINES (2021)
Molecular mechanisms of nonself nucleic acid recognition by the innate immune system
Carina C. de Oliveira Mann et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
The multifactorial roles of microglia and macrophages in the maintenance and progression of glioblastoma
Rishabh Chaudhary et al.
JOURNAL OF NEUROIMMUNOLOGY (2021)
Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases
Mahesh Chandra Patra et al.
SEMINARS IN CANCER BIOLOGY (2020)
Synergistic Toll-like Receptor 3/9 Signaling Affects Properties and Impairs Glioma-Promoting Activity of Microglia
Yimin Huang et al.
JOURNAL OF NEUROSCIENCE (2020)
Toll-Like Receptor 9 Agonists in Cancer
Lilit Karapetyan et al.
ONCOTARGETS AND THERAPY (2020)
Prognostic value of magnetic resonance imaging features in low-grade gliomas
Liang Deng et al.
BIOSCIENCE REPORTS (2019)
Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
Jitka Fucikova et al.
FRONTIERS IN IMMUNOLOGY (2019)
An effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma
Shan Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Modified Genomic Self-DNA Influences In Vitro Survival of HT29 Tumor Cells via TLR9-and Autophagy Signaling
Ferenc Sipos et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
lmmunostimulatory CpG on Carbon Nanotubes Selectively Inhibits Migration of Brain Tumor Cells
Darya Alizadeh et al.
BIOCONJUGATE CHEMISTRY (2018)
Plasmatic membrane toll-like receptor expressions in human astrocytomas
Isabele Fattori Moretti et al.
PLOS ONE (2018)
The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma
Debolina Ganguly et al.
Oncotarget (2018)
Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised study
Renata Ursu et al.
EUROPEAN JOURNAL OF CANCER (2017)
The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
Takashi Komori
NEUROLOGIA MEDICO-CHIRURGICA (2017)
BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells
Alexis Combes et al.
NATURE COMMUNICATIONS (2017)
Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression
Linsen Mu et al.
WORLD NEUROSURGERY (2017)
Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro
Johanna M. Tuomela et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model
Marie Jordan et al.
CANCER LETTERS (2016)
Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis
Ata Miyar et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
TLR9-ERK-mTOR signaling is critical for autophagic cell death induced by CpG oligodeoxynucleotide 107 combined with irradiation in glioma cells
Xiaoli Li et al.
SCIENTIFIC REPORTS (2016)
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
Daxa M. Patel et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2016)
The role of Toll-like receptor 9 in gynecologic cancer
E. Fehri et al.
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2016)
Glioblastoma: Overview of Disease and Treatment
Mary Elizabeth Davis
CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial
Renata Ursu et al.
CANCER SCIENCE (2015)
TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections
Fabiana Cannella et al.
IMMUNOBIOLOGY (2015)
Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
Mahua Dey et al.
JOURNAL OF IMMUNOLOGY (2015)
Immunosuppressive mechanisms in glioblastoma
Edjah K. Nduom et al.
NEURO-ONCOLOGY (2015)
Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
Meena Jhanwar-Uniyal et al.
CANCERS (2015)
Expression of Toll-like Receptor 9 Increases with Progression of Cervical Neoplasia in Tunisian Women - A Comparative Analysis of Condyloma, Cervical Intraepithelial Neoplasia and Invasive Carcinoma
Emna Fehri et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Jigisha P. Thakkar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting
Andreas Herrmann et al.
CANCER RESEARCH (2014)
Recognition of Herpes Simplex Viruses: Toll-Like Receptors and Beyond
Yijie Ma et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
The Yin and Yang of Toll-like receptors in cancer
J-P Pradere et al.
ONCOGENE (2014)
Functional expression of TLR9 in esophageal cancer
Yanli Zhang et al.
ONCOLOGY REPORTS (2014)
Activation of Toll-Like Receptor-9 Promotes Cellular Migration via Up-Regulating MMP-2 Expression in Oral Squamous Cell Carcinoma
Min Ruan et al.
PLOS ONE (2014)
Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro
Jouko Sandholm et al.
ONCOLOGY LETTERS (2014)
The radiosensitizing effect of CpG ODN107 on human glioma cells is tightly related to its antiangiogenic activity via suppression of HIF-1α/VEGF pathway
Dan Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Heat shock protein gp96 regulates Toll-like receptor 9 proteolytic processing and conformational stability
James C. Brooks et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells
Ruan Min et al.
CANCER SCIENCE (2012)
TLR9 expression is associated with prognosis in patients with glioblastoma multiforme
Lige Leng et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production
Xiaoli Li et al.
TUMOR BIOLOGY (2012)
The role of innate immune signals in immunity to Brucella abortus
Marco Tulio R. Gomes et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2012)
H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection
Anne Mueller et al.
CELL COMMUNICATION AND SIGNALING (2011)
IGF-1 induced HIF-1α-TLR9 cross talk regulates inflammatory responses in glioma
Sanchari Sinha et al.
CELLULAR SIGNALLING (2011)
Innate Immune Recognition of Mycobacterium tuberculosis
Johanneke Kleinnijenhuis et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity
Dongchang Zhao et al.
CLINICAL CANCER RESEARCH (2011)
Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase
Sarah E. Ewald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients
Chao Wang et al.
BMC CANCER (2010)
Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model
Christian Ginzkey et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Modulation of immune responses through direct activation of Toll-like receptors to T cells
G. Liu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses
Xiaopei Huang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Directing dendritic cell immunotherapy towards successful cancer treatment
Rachel Lubong Sabado et al.
IMMUNOTHERAPY (2010)
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
Alexandre Carpentier et al.
NEURO-ONCOLOGY (2010)
Toll-Like Receptor Signaling Pathways-Therapeutic Opportunities
Jiankun Zhu et al.
MEDIATORS OF INFLAMMATION (2010)
Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells
Amanda L. Blasius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3
Miwa Sasai et al.
SCIENCE (2010)
Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes
Esmeralda Juarez et al.
RESPIRATORY RESEARCH (2010)
Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes
Esmeralda Juarez et al.
RESPIRATORY RESEARCH (2010)
CXCR4/SDF-1 pathway is crucial for TLR9 agonist enhanced metastasis of human lung cancer cell
Lin Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Pattern recognition receptors and control of adaptive immunity
Noah W. Palm et al.
IMMUNOLOGICAL REVIEWS (2009)
Pediatric Low-Grade Gliomas
Angela J. Sievert et al.
JOURNAL OF CHILD NEUROLOGY (2009)
Costimulation Signals for Memory CD8(+) T Cells During Viral Infections
Priyanka A. Duttagupta et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
TLR9 as a key receptor for the recognition of DNA
Yutaro Kumagai et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Central role of dendritic cells in the regulation and deregulation of immune responses
F. Granucci et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas
Oliver M. Grauer et al.
JOURNAL OF IMMUNOLOGY (2008)
Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway
Kiwamu Nakamura et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression of TLR9 within human glioblastoma
Yuxia Meng et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes
You-Me Kim et al.
NATURE (2008)
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Sarah E. Ewald et al.
NATURE (2008)
Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9
Boyoun Park et al.
NATURE IMMUNOLOGY (2008)
A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses
Koichiro Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Increased toll-like receptor 9 expression in cervical neoplasia
Jeong-Won Lee et al.
MOLECULAR CARCINOGENESIS (2007)
Epidemiology of brain tumors
James L. Fisher et al.
NEUROLOGIC CLINICS (2007)
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro
Joanna M. Ilvesaro et al.
PROSTATE (2007)
Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme
Eduardo Briceno et al.
SURGICAL NEUROLOGY (2007)
Expression and function of Toll-like receptors in T lymphocytes
Dieter Kabelitz
CURRENT OPINION IN IMMUNOLOGY (2007)
Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors
Abdeljabar El Andaloussi et al.
GLIA (2006)
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity
Melinda A. Merrell et al.
MOLECULAR CANCER RESEARCH (2006)
Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma
GE Keles et al.
JOURNAL OF NEUROSURGERY (2006)
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses
S. Farzana Hussain et al.
NEURO-ONCOLOGY (2006)
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9
K Tabeta et al.
NATURE IMMUNOLOGY (2006)
Innate immune recognition of viral infection
T Kawai et al.
NATURE IMMUNOLOGY (2006)
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma
A Carpentier et al.
NEURO-ONCOLOGY (2006)
Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation
YJ Chang et al.
JOURNAL OF IMMUNOLOGY (2005)
Successful combination of local CpG-ODN and radiotherapy in malignant glioma
YX Meng et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Epidemiology and etiology of gliomas
H Ohgaki et al.
ACTA NEUROPATHOLOGICA (2005)
Plasmacytoid dendritic cells: Linking innate and adaptive immunity
K McKenna et al.
JOURNAL OF VIROLOGY (2005)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Human B cells express functional TRAIL/Apo-2 ligand after CpG-containing oligodeoxynucleotide stimulation
TJ Kemp et al.
JOURNAL OF IMMUNOLOGY (2004)
TL-139-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function
A Krug et al.
IMMUNITY (2004)
Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-κB activation
YJ Chang et al.
MOLECULAR PHARMACOLOGY (2004)
The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells
E Bourke et al.
BLOOD (2003)
Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells
A Heit et al.
JOURNAL OF IMMUNOLOGY (2003)
Plasmacytoid dendritic cells: The key to CpG
S Rothenfusser et al.
HUMAN IMMUNOLOGY (2002)
Broad expression of Toll-like receptors in the human central nervous system
M Bsibsi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
A Toll-like receptor recognizes bacterial DNA
H Hemmi et al.
NATURE (2000)
Share Paper
